000 | 01037 a2200325 4500 | ||
---|---|---|---|
005 | 20250513113947.0 | ||
264 | 0 | _c19970624 | |
008 | 199706s 0 0 eng d | ||
022 | _a1040-872X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeetalarom, K | |
245 | 0 | 0 |
_aTaxanes in ovarian cancer treatment. _h[electronic resource] |
260 |
_bCurrent opinion in obstetrics & gynecology _cFeb 1997 |
||
300 |
_a14-20 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xtherapeutic use |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOvarian Neoplasms _xmortality |
650 | 0 | 4 |
_aPaclitaxel _xanalogs & derivatives |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTaxoids |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aKudelka, A P | |
700 | 1 | _aVerschraegen, C F | |
700 | 1 | _aKavanagh, J J | |
773 | 0 |
_tCurrent opinion in obstetrics & gynecology _gvol. 9 _gno. 1 _gp. 14-20 |
|
999 |
_c9074005 _d9074005 |